BioRender Icon

Cone photoreceptor (dying 2)

Cone photoreceptor (dying 2) - Editable icon of a dying cone photoreceptor cell
[{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03b7/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03b7/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03b6/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03b6/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03b5/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03b5/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03b4/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03b4/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03b3/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03b3/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03b2/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03b2/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03b1/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03b1/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03b0/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03b0/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03af/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03af/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03ae/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03ae/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03ad/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03ad/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03ac/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03ac/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03ab/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03ab/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03aa/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03aa/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03a9/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03a9/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03a8/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03a8/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03a7/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03a7/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03a6/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03a6/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03a5/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03a5/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03a4/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03a4/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03a3/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03a3/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03a2/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03a2/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03a1/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03a1/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa03a0/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa03a0/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa039f/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa039f/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa039e/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa039e/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa039d/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa039d/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa039c/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa039c/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa039b/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa039b/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa039a/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa039a/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa0399/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa0399/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa0398/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa0398/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa0397/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa0397/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa0396/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa0396/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa0395/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa0395/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa0394/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa0394/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa0393/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa0393/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa0392/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa0392/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa0391/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa0391/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa0390/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa0390/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa038f/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa038f/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa038e/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa038e/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa038d/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa038d/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa038c/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa038c/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa038b/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa038b/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa038a/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa038a/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa0389/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa0389/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa0388/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa0388/5fbbeaf037cd790026fa0355.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5fbbec5237cd790026fa0387/5fbbeaf037cd790026fa0355.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5fbbec5237cd790026fa0387/5fbbeaf037cd790026fa0355.png"}]
Use This Icon – Free
No credit card required to sign up.

This icon is fully editable in BioRender

  • Add text, shapes, & other icons
  • Search 50,000+ scientifically accurate icons
  • Recolor and rearrange every icon, line, & label
  • Export or share for any use case
Scientist Avatars

Join 4M+ scientists already making publication-ready figures

Go from icons to finished figure – in minutes

  • Search from 50,000+ scientifically accurate, peer-reviewed icons
  • Customize with labels, shapes, and additional icons – everything is completely editable
  • Export or share your figures with collaborators

Not quite the right icon? Discover more.

Search 50,000+ icons across 30+ life-science fields.

search icon
arrow-right
Keywords
cone ,photoreceptor,retina,retinal,eye,vision,colour color,dying dead ,death,decay,damaged,cone photoreceptor,neuroanatomy,ophthalmology
View More

Try a synonym, or sign up to request an icon from the app.

Image types

Cone photoreceptor (dying 2) icon JPEG

Cone photoreceptor (dying 2) icon PNG

Cone photoreceptor (dying 2) icon SVG

Cone photoreceptor (dying 2) icon GIF

Biorender Icon FAQs

How are scientists using the Cone photoreceptor (dying 2) icon in their work?

BioRender users often use the Cone photoreceptor (dying 2) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Cone photoreceptor (dying 2) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Cone photoreceptor (dying 2) icon customizable in BioRender?

Most icons in BioRender, including the Cone photoreceptor (dying 2) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Cone photoreceptor (dying 2) icon for publication or presentations?

Yes, figures containing the Cone photoreceptor (dying 2) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Cone photoreceptor (dying 2) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Cone photoreceptor (dying 2) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Cone photoreceptor (dying 2) icon along with our library of more than 30,000 life science icons.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now
x icon